speb/financial-data huggingface dataset:
LICHSGFIN.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 414289300000.00
LICHSGFIN.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 414289300000.00
LICHSGFIN.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 413894700000.00
LICHSGFIN.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 413894700000.00
LICHSGFIN.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
LICHSGFIN.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
LICHSGFIN.NS income_statement (annual, 2026-03-31) — Tax Provision: 14992300000.00
LICHSGFIN.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 4408400000.00
LICHSGFIN.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.21
LICHSGFIN.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.23
LICHSGFIN.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 6381500000.00
LICHSGFIN.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 6381500000.00
LICHSGFIN.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -12941200000.00
LICHSGFIN.NS balance_sheet (annual, 2026-03-31) — Total Assets: 3252129500000.00
LICHSGFIN.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 3252129500000.00
LICHSGFIN.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 3074620000000.00
LICHSGFIN.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 3074620000000.00
LICHSGFIN.NS balance_sheet (annual, 2026-03-31) — Total Debt: 2662162000000.00
LICHSGFIN.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 2662162000000.00
LICHSGFIN.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 414330400000.00
LICHSGFIN.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 414330400000.00
LICHSGFIN.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 2837799100000.00
LICHSGFIN.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2837799100000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 8169169000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 106057739000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -38701137000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 21021000.00
LICI.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 6326239571.00
LICI.NS income_statement (annual, 2022-03-31) — Basic EPS: 6.52
LICI.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 32514418000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 1987541000.00
LICI.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 4361858000.00
LICI.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 4361858000.00
LICI.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 6326239571.00
LICI.NS income_statement (annual, 2022-03-31) — Diluted EPS: 6.52
LICI.NS income_statement (annual, 2022-03-31) — EBIT: 42512778000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Financial Assets: 0.00
LICI.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 444527000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Goodwill: 0.00
LICI.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 211976000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 74195956000.00
LICI.NS income_statement (annual, 2022-03-31) — Interest Expense: 866996000.00
LICI.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 866996000.00
LICI.NS income_statement (annual, 2022-03-31) — Interest Income: 2538383617000.00
LICI.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 0.00
LICI.NS balance_sheet (annual, 2022-03-31) — Inventory: 725331000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Investment Properties: 143980476000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Investmentsin Subsidiariesat Cost: 341656440000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 2352161000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 12885000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 12885000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 341656440000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 5857587000.00
LICI.NS income_statement (annual, 2022-03-31) — Net Interest Income: -866996000.00
LICI.NS cash_flow (annual, 2022-03-31) — Net Investment Properties Purchase And Sale: -4277811495000.00
LICI.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -866996000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Non Current Accrued Expenses: 44501166000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 211976000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Other Payable: 140922000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Other Properties: 31484249000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 841846565000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 287618547000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Payables: 26147044000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 352142581000.00
LICI.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment Properties: -4277811495000.00
LICI.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 4361858000.00
LICI.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 6731024000.00
LICI.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 6731024000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 41751375000.00
LICI.NS cash_flow (annual, 2022-03-31) — Sale Of Investment Properties: 1903881120000.00
LICI.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 7482975000.00
LICI.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 7927502000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Total Debt: 12885000.00
LICI.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 17836953000.00
LICI.NS income_statement (annual, 2023-03-31) — +Total Revenue: 7852170800000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 9427500000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 152746900000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -41430400000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 21000000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 4274422400000.00
LICI.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 12649995402.00
LICI.NS income_statement (annual, 2023-03-31) — Basic EPS: 28.46
LICI.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 448660500000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 34214000000.00
LICI.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -8864700000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 63250000000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 309023300000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 518289100000.00
LICI.NS cash_flow (annual, 2023-03-31) — Cash Flowsfromusedin Operating Activities Direct: 545185100000.00
LICI.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -9016100000.00
LICI.NS cash_flow (annual, 2023-03-31) — Classesof Cash Payments: -4349880000000.00
LICI.NS cash_flow (annual, 2023-03-31) — Classesof Cash Receiptsfrom Operating Activities: 4895065100000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Common Stock: 63250000000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 462328700000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 3314600000.00
LICI.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 4663800000.00
LICI.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 4663800000.00
LICI.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 12649995402.00
LICI.NS income_statement (annual, 2023-03-31) — Diluted EPS: 28.46
LICI.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 359966500000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 1600000.00
LICI.NS income_statement (annual, 2023-03-31) — EBIT: 361583700000.00
LICI.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 16237000000.00
LICI.NS cash_flow (annual, 2023-03-31) — End Cash Position: 455881400000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Financial Assets: 0.00
LICI.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -9485900000.00
LICI.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 536320400000.00
LICI.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 677500000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Goodwill: 0.00
LICI.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 154000000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 79643700000.00
LICI.NS income_statement (annual, 2023-03-31) — Interest Expense: 774300000.00
LICI.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 774300000.00
LICI.NS income_statement (annual, 2023-03-31) — Interest Income: 2761176600000.00
LICI.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -9485900000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Inventory: 634000000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 462328700000.00
LICI.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -544715300000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 169680000000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 41574088100000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Investments And Advances: 42166823800000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Investmentsin Subsidiariesat Cost: 383469900000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 1718900000.00
LICI.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: 0.00
LICI.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 383469900000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 149462200000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 6064600000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 1171000000.00
LICI.NS income_statement (annual, 2023-03-31) — Net Income: 359966500000.00
LICI.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 359966500000.00
LICI.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 359966500000.00
LICI.NS income_statement (annual, 2023-03-31) — Net Income Extraordinary: 0.00
LICI.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 359966500000.00
LICI.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 359966500000.00
LICI.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 359966500000.00
LICI.NS income_statement (annual, 2023-03-31) — Net Interest Income: -774300000.00
LICI.NS cash_flow (annual, 2023-03-31) — Net Investment Properties Purchase And Sale: -5437393750000.00
LICI.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -3188313200000.00
LICI.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 0.00
LICI.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 0.00
LICI.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -774300000.00
LICI.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 2689314800000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Net PPE: 38213300000.00
LICI.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -5421100000.00
LICI.NS income_statement (annual, 2023-03-31) — Net Policyholder Benefits And Claims: 3090887400000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 462174700000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Non Current Accrued Expenses: 50402700000.00
LICI.NS income_statement (annual, 2023-03-31) — Normalized Income: 359966500000.00
LICI.NS income_statement (annual, 2023-03-31) — Operating Revenue: 7852170800000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 12649995402.00
LICI.NS cash_flow (annual, 2023-03-31) — Other Cash Paymentsfrom Operating Activities: -529666400000.00
LICI.NS cash_flow (annual, 2023-03-31) — Other Cash Receiptsfrom Operating Activities: 79698900000.00
LICI.NS income_statement (annual, 2023-03-31) — Other Income Expense: 5700000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 154000000.00
LICI.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 259315300000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Other Payable: 133600000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Other Properties: 34331600000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 913414700000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 209265800000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Payables: 29822800000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 237123800000.00
LICI.NS income_statement (annual, 2023-03-31) — Pretax Income: 360809400000.00
LICI.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -5437393800000.00
LICI.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment Properties: -5437393750000.00
LICI.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -8864700000.00
LICI.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 4663800000.00
LICI.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 7272600000.00
LICI.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 7272600000.00
LICI.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: 0.00
LICI.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 392175300000.00
LICI.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 2249080600000.00
LICI.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 3443600000.00
LICI.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 7138500000.00
LICI.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 7816000000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Share Issued: 12649995402.00
LICI.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 462328700000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 462174700000.00
LICI.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
LICI.NS income_statement (annual, 2023-03-31) — Tax Provision: 842900000.00
LICI.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
LICI.NS balance_sheet (annual, 2023-03-31) — Total Assets: 45784913600000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 462328700000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 463499700000.00
LICI.NS income_statement (annual, 2023-03-31) — Total Expenses: 7453042400000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 45321413900000.00
LICI.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 20260100000.00
LICI.NS income_statement (annual, 2024-03-31) — +Total Revenue: 8490308700000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 11441000000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 152392300000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -44164600000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 21000000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 4367451700000.00
LICI.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 12649995402.00
LICI.NS income_statement (annual, 2024-03-31) — Basic EPS: 32.35
LICI.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 455881400000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 36639800000.00
LICI.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -7677700000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 63250000000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 361653100000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 796406700000.00
LICI.NS cash_flow (annual, 2024-03-31) — Cash Flowsfromusedin Operating Activities Direct: 265479400000.00
LICI.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -37055700000.00
LICI.NS cash_flow (annual, 2024-03-31) — Classesof Cash Payments: -4630561500000.00
LICI.NS cash_flow (annual, 2024-03-31) — Classesof Cash Receiptsfrom Operating Activities: 4896040900000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Common Stock: 63250000000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 827468700000.00
LICI.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
LICI.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 4025200000.00
LICI.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 4659400000.00
LICI.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 4659400000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 0.00
LICI.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 12649995402.00
LICI.NS income_statement (annual, 2024-03-31) — Diluted EPS: 32.35
LICI.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 409158500000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 4600000.00
LICI.NS income_statement (annual, 2024-03-31) — EBIT: 411844800000.00
LICI.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 1312600000.00
LICI.NS cash_flow (annual, 2024-03-31) — End Cash Position: 420138300000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Financial Assets: -600000.00
LICI.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -44272000000.00
LICI.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 257801700000.00
LICI.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 569200000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Goodwill: 0.00
LICI.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 111200000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 84801100000.00
LICI.NS income_statement (annual, 2024-03-31) — Interest Expense: 1278800000.00
LICI.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1278800000.00
LICI.NS income_statement (annual, 2024-03-31) — Interest Income: 3012731100000.00
LICI.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -44272000000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Inventory: 575500000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 827468700000.00
LICI.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -258263100000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 169950200000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 48558002700000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Investments And Advances: 49408522900000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Investmentsin Subsidiariesat Cost: 415766600000.00
LICI.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
LICI.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
LICI.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1435400000.00
LICI.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
LICI.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: 0.00
LICI.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 415766600000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 149461400000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 6444200000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 1527300000.00
LICI.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
LICI.NS income_statement (annual, 2024-03-31) — Net Income: 409158500000.00
LICI.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 409158500000.00
LICI.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 409158500000.00
LICI.NS income_statement (annual, 2024-03-31) — Net Income Extraordinary: 0.00
LICI.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 409158500000.00
LICI.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 409158500000.00
LICI.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 409158500000.00
LICI.NS income_statement (annual, 2024-03-31) — Net Interest Income: -1278800000.00
LICI.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -3141330200000.00
LICI.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 0.00
LICI.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 0.00
LICI.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -1278800000.00
LICI.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 2927472300000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Net PPE: 40636500000.00
LICI.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -7127200000.00
LICI.NS income_statement (annual, 2024-03-31) — Net Policyholder Benefits And Claims: 3518019900000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 827357500000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Non Current Accrued Expenses: 52342600000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 3000000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 0.00
LICI.NS income_statement (annual, 2024-03-31) — Normalized Income: 409158500000.00
LICI.NS income_statement (annual, 2024-03-31) — Operating Revenue: 8490308700000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 12649995402.00
LICI.NS cash_flow (annual, 2024-03-31) — Other Cash Paymentsfrom Operating Activities: -408815100000.00
LICI.NS cash_flow (annual, 2024-03-31) — Other Cash Receiptsfrom Operating Activities: 71162700000.00
LICI.NS income_statement (annual, 2024-03-31) — Other Income Expense: 600000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 111200000.00
LICI.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 377736300000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Other Payable: 145700000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Other Properties: 36256500000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 994088700000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 434753600000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Payables: 30115200000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 202160300000.00
LICI.NS income_statement (annual, 2024-03-31) — Pretax Income: 410566000000.00
LICI.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -5760368900000.00
LICI.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -7677700000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Receivables Adjustments Allowances: -1037700000.00
LICI.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 4659400000.00
LICI.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 7993200000.00
LICI.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 7993200000.00
LICI.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: 0.00
LICI.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 757018300000.00
LICI.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 2619038700000.00
LICI.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 550500000.00
LICI.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 5566000000.00
LICI.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 6135200000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Share Issued: 12649995402.00
LICI.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 827468700000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 827357500000.00
LICI.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
LICI.NS income_statement (annual, 2024-03-31) — Tax Provision: 1407500000.00
LICI.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
LICI.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 8026700000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Total Assets: 53160474200000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 827468700000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 828996000000.00
LICI.NS income_statement (annual, 2024-03-31) — Total Expenses: 8079742700000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 52331478200000.00
LICI.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 18523900000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 53699211600000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 63250000000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 293902200000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 293902200000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 63250000000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 976369900000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 976369900000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 53699211600000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 53699211600000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 149461400000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 1788200000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 41969000000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 976369900000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 6324997701.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 6324997701.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 976369900000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 976369900000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 57191210700000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 976369900000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 978158100000.00
LICI.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 56213052600000.00
LICI.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 2034509900000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 6326810345.00
LICI.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 17.40
LICI.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 6326810345.00
LICI.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 17.40
LICI.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 110086500000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Net Income: 110086500000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 110086500000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 110086500000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Net Income Extraordinary: 0.00
LICI.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 110086500000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 110086500000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 110086500000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Net Policyholder Benefits And Claims: 965312800000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 110086500000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 2034509900000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Other Income Expense: 0.00
LICI.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 48086100000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 110183900000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
LICI.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 97400000.00
LICI.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
LICI.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 1924326000000.00
LICI.NS income_statement (annual, 2025-03-31) — +Total Revenue: 8911252600000.00
LICI.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2435569500000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 14540200000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 14540200000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 119979100000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 119979100000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -43798000000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -43798000000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 171200000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 171200000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 4830701200000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 4830701200000.00
LICI.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 12649995402.00
LICI.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 12650279070.00
LICI.NS income_statement (annual, 2025-03-31) — Basic EPS: 38.20
LICI.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 15.05
LICI.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 420138300000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 39243000000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 39243000000.00
LICI.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -7767300000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 63250000000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 63250000000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 544536300000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 544536300000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 825747600000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 825747600000.00
LICI.NS cash_flow (annual, 2025-03-31) — Cash Flowsfromusedin Operating Activities Direct: -97205700000.00
LICI.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 274843800000.00
LICI.NS cash_flow (annual, 2025-03-31) — Classesof Cash Payments: -5025045400000.00
LICI.NS cash_flow (annual, 2025-03-31) — Classesof Cash Receiptsfrom Operating Activities: 4927839700000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Common Stock: 63250000000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 63250000000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 1272263900000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1272263900000.00
LICI.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 0.00
LICI.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 3259200000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 3259200000.00
LICI.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 5064700000.00
LICI.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 5064700000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Derivative Product Liabilities: 148100000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 148100000.00
LICI.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 12649995402.00
LICI.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 12650279070.00
LICI.NS income_statement (annual, 2025-03-31) — Diluted EPS: 38.20
LICI.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 15.05
LICI.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 483203300000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 190386700000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 11800000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 11800000.00
LICI.NS income_statement (annual, 2025-03-31) — EBIT: 484932600000.00
LICI.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 4082700000.00
LICI.NS cash_flow (annual, 2025-03-31) — End Cash Position: 699064800000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Financial Assets: 123300000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets: 123300000.00
LICI.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -37942800000.00
LICI.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -104973000000.00
LICI.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 808800000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Goodwill: 0.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 0.00
LICI.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 2693900000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2693900000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 85935900000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 85935900000.00
LICI.NS income_statement (annual, 2025-03-31) — Interest Expense: 1426500000.00
LICI.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 1426500000.00
LICI.NS income_statement (annual, 2025-03-31) — Interest Income: 3229753400000.00
LICI.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -37942800000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Inventory: 557300000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 557300000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 1272263900000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1272263900000.00
LICI.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: 409992300000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 171732100000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 171732100000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 51724466500000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 51724466500000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Investments And Advances: 52500586000000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 52500586000000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Investmentsin Subsidiariesat Cost: 494908200000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Subsidiariesat Cost: 494908200000.00
LICI.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 0.00
LICI.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 0.00
LICI.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1309900000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1309900000.00
LICI.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 0.00
LICI.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: 0.00
LICI.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 494908200000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 494908200000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 149460800000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 149460800000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 6948200000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 6948200000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 2772700000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 2772700000.00
LICI.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 0.00
LICI.NS income_statement (annual, 2025-03-31) — Net Income: 483203300000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Net Income: 190386700000.00
LICI.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 483203300000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 190386700000.00
LICI.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 483203300000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 190386700000.00
LICI.NS income_statement (annual, 2025-03-31) — Net Income Extraordinary: 0.00
LICI.NS income_statement (quarterly, 2025-03-31) — Net Income Extraordinary: 0.00
LICI.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 483203300000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 190386700000.00
LICI.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 483203300000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 190386700000.00
LICI.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 483203300000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 190386700000.00
LICI.NS income_statement (annual, 2025-03-31) — Net Interest Income: -1426500000.00
LICI.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -2677056600000.00
LICI.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
LICI.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 0.00
LICI.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -1426500000.00
LICI.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 3150916800000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Net PPE: 42137900000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 42137900000.00
LICI.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -7147900000.00
LICI.NS income_statement (annual, 2025-03-31) — Net Policyholder Benefits And Claims: 3703103300000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Net Policyholder Benefits And Claims: 1427649300000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 1269570000000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1269570000000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Non Current Accrued Expenses: 32115800000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Non Current Accrued Expenses: 32115800000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 2700000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 2700000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
LICI.NS income_statement (annual, 2025-03-31) — Normalized Income: 483203300000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 190386700000.00
LICI.NS income_statement (annual, 2025-03-31) — Operating Revenue: 8911252600000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2435569500000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 12649995402.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 12649995402.00
LICI.NS cash_flow (annual, 2025-03-31) — Other Cash Paymentsfrom Operating Activities: -488444400000.00
LICI.NS cash_flow (annual, 2025-03-31) — Other Cash Receiptsfrom Operating Activities: 8418900000.00
LICI.NS income_statement (annual, 2025-03-31) — Other Income Expense: -4700000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Other Income Expense: 0.00
LICI.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 2693900000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2693900000.00
LICI.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 678647100000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 74386800000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Other Payable: 132500000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 132500000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Other Properties: 35175600000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 35175600000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 1072519100000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1072519100000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 281211300000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 281211300000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Payables: 33001100000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Payables: 33001100000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 119441800000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 119441800000.00
LICI.NS income_statement (annual, 2025-03-31) — Pretax Income: 483506100000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 190457400000.00
LICI.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -5754978100000.00
LICI.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -7767300000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Receivables Adjustments Allowances: -900000000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -900000000.00
LICI.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 5064700000.00
LICI.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 8168400000.00
LICI.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 8168400000.00
LICI.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: 0.00
LICI.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 1202165100000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1202165100000.00
LICI.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 3077921500000.00
LICI.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 619400000.00
LICI.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 6122100000.00
LICI.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 6930900000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Share Issued: 12649995402.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 12649995402.00
LICI.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 1272263900000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1272263900000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 1269570000000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1269570000000.00
LICI.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
LICI.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
LICI.NS income_statement (annual, 2025-03-31) — Tax Provision: 302800000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 70700000.00
LICI.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.00
LICI.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
LICI.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 11501400000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 11501400000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Total Assets: 56605684600000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 56605684600000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 1272263900000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1272263900000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 1275036600000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1275036600000.00
LICI.NS income_statement (annual, 2025-03-31) — Total Expenses: 8427746500000.00
LICI.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 2245112100000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 55330648000000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 55330648000000.00
LICI.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 18316600000.00
LICI.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 18316600000.00
LICI.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 2250327900000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 12652482679.00
LICI.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 8.66
LICI.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 12652482679.00
LICI.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 8.66
LICI.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 109570500000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Net Income: 109570500000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 109570500000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 109570500000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Net Income Extraordinary: 0.00
LICI.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 109570500000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 109570500000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 109570500000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Net Policyholder Benefits And Claims: 975509200000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 109570500000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 2250327900000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Other Income Expense: 0.00
LICI.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 40388900000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 109857700000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
LICI.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 287000000.00
LICI.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
LICI.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 2136002900000.00
LICI.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 12646812774.00
LICI.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 7.99
LICI.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 12646812774.00